Yelin Lapidot Holdings Management Ltd. Syndax Pharmaceuticals Inc Transaction History
Yelin Lapidot Holdings Management Ltd.
- $607 Billion
- Q3 2024
A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 108,377 shares of SNDX stock, worth $1.42 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
108,377
Previous 114,530
5.37%
Holding current value
$1.42 Million
Previous $2.35 Billion
11.27%
% of portfolio
0.34%
Previous 0.41%
Shares
2 transactions
Others Institutions Holding SNDX
# of Institutions
228Shares Held
88.4MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$103 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$76.4 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$65.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$63.9 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$53.7 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $739M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...